Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
FEBS Letters|August 19, 2007
Stimulus interval, rate and direction differentially regulate phosphorylation for mechanotransduction in neonatal cardiac myocytesSamuel E Senyo, Yevgeniya E Koshman, Brenda RussellJournal of Molecular and Cellular Cardiology|March 2, 2010
Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and widthBrenda Russell, Matthew W Curtis, Yevgeniya E Koshman, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|January 2, 2010
Signaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytesYevgeniya E Koshman, Mariann R Piano, Brenda Russell, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|January 8, 2024
Preclinical cardiovascular safety assessment of pharmacology-toxicology relationship for a set of novel kinase inhibitorsYevgeniya E Koshman, Rebecca Kohnken, Michael R Logan, et al.Journal of Pharmacological and Toxicological Methods|January 14, 2018
The evaluation of drug-induced changes in left ventricular function in pentobarbital-anesthetized dogsYevgeniya E Koshman, Brett R Herzberg, Terese R Seifert, et al.Cardiovascular Research|October 2, 2009
Role of FRNK tyrosine phosphorylation in vascular smooth muscle spreading and migrationYevgeniya E Koshman, Steven J Engman, Taehoon Kim, et al.Journal of Pharmacological and Toxicological Methods|May 1, 2025
The 2023 Safety Pharmacology Society (SPS) salary surveyMichael K Pugsley, Simon Authier, Brett R Winters, et al.Journal of Pharmacological and Toxicological Methods|July 31, 2023
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance documentMichael K Pugsley, Yevgeniya E Koshman, C Michael Foley, et al.Journal of Pharmacological and Toxicological Methods|August 4, 2022
Safety pharmacology in 2022: Taking one small step for cardiovascular safety assay development but one giant leap for regulatory drug safety assessmentMichael K Pugsley, Yevgeniya E Koshman, Tessa de Korte, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2011
Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhesion targeting, tyrosine 168 phosphorylation, and competition for p130(Cas) bindingYevgeniya E Koshman, Miensheng Chu, Steven J Engman, et al.Pageof 3